Initial assessment for patients with HIV: Difference between revisions

From IDWiki
(: added OCC guideline testing)
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
== History ==
+
==History==
   
* Date and context of diagnosis
+
*Date and context of diagnosis
* History of [[Opportunistic infections in HIV]]
+
*History of [[Opportunistic infections in HIV]]
* Sexual history
+
*Sexual history
   
== Investigations ==
+
==Investigations==
   
* HIV-specific
+
*HIV-specific
** CD4/CD8 count
+
**CD4/CD8 count
** HIV-RNA viral load
+
**HIV-RNA viral load
** HIV genotype
+
**HIV genotype
** HLA *B5701 genotyping (for abacavir)
+
**HLA *B5701 genotyping (for abacavir)
** Genetic resistance assays (± tropism testing for CCR5 inhibitors)
+
**Genetic resistance assays (± tropism testing for CCR5 inhibitors)
** G6PD deficiency
+
**G6PD deficiency
* Routine
+
*Routine
** CBC, lytes, creatinine
+
**CBC, lytes, creatinine
** Fasting lipids, Hb A1c
+
**Fasting lipids, Hb A1c
** Urinalysis (glucose and protein)
+
**Urinalysis (glucose and protein)
** Consider bone mineral density testing and vitamin D levels
+
**Consider bone mineral density testing and vitamin D levels
* STIs and coinfections
+
*STIs and coinfections
** TB skin test
+
**TB skin test
** Consider chest x-ray
+
**Consider chest x-ray
** HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab
+
**HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab
** Syphilis
+
**Syphilis
** Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
+
**Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
** Toxoplasma, varicella, CMV, and measles serologies
+
**Toxoplasma, varicella, CMV, and measles serologies
* For women and trans men
+
*For cis women and trans men
** Pap smear
+
**Pap smear
** Rubella serology
+
**Rubella serology
** Trichomonas testing
+
**Trichomonas testing
  +
*Low threshold for CT chest/abdo/pelvis for lymphadenopathy and non-tuberculous mycobacteria in patients with low CD4 counts
   
== Initial regimens ==
+
== Physical Examination ==
   
  +
* Assess for cutaneous Kaposi sarcoma
* All are integrase inhibitor with two nucleoside analogues
 
  +
* Consider one of the [HIV single-tablet regimens](Single-tablet regimens.md)
 
  +
==Initial Regimens==
** Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
 
  +
** Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
 
 
*All are integrase inhibitor with two nucleoside analogues
** Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
 
 
*Consider one of the [[single-tablet regimens for HIV]]
** Complera: emtricitabine/rilpivirine/tenofovir disoproxil
 
  +
**Biktarvy 1 tablet PO once daily
 
**Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
 
**Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
 
**Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
 
**Complera: emtricitabine/rilpivirine/tenofovir disoproxil
  +
*Don't forget to add [[TMP-SMX]] DS 1 tablet PO daily if presumed low CD4 count
  +
  +
==Further Reading==
  +
  +
*[http://occguidelines.com/guidelines/ Clinical Care Guidelines for Adults and Adolescents Living with HIV in Ontario, Canada]
  +
*Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update. ''Clin Infect Dis''. 2014:58(1):e1–e34. doi: [https://doi.org/10.1093/cid/cit665 10.1093/cid/cit665]
   
 
[[Category:HIV]]
 
[[Category:HIV]]

Latest revision as of 11:10, 30 April 2021

History

Investigations

  • HIV-specific
    • CD4/CD8 count
    • HIV-RNA viral load
    • HIV genotype
    • HLA *B5701 genotyping (for abacavir)
    • Genetic resistance assays (± tropism testing for CCR5 inhibitors)
    • G6PD deficiency
  • Routine
    • CBC, lytes, creatinine
    • Fasting lipids, Hb A1c
    • Urinalysis (glucose and protein)
    • Consider bone mineral density testing and vitamin D levels
  • STIs and coinfections
    • TB skin test
    • Consider chest x-ray
    • HAV-IgG, HBV-sAg/sAb/cAb, and HCV-Ab
    • Syphilis
    • Three-site mucosal (genital/rectal/throat) NAAT for chlamydia and gonorrhea
    • Toxoplasma, varicella, CMV, and measles serologies
  • For cis women and trans men
    • Pap smear
    • Rubella serology
    • Trichomonas testing
  • Low threshold for CT chest/abdo/pelvis for lymphadenopathy and non-tuberculous mycobacteria in patients with low CD4 counts

Physical Examination

  • Assess for cutaneous Kaposi sarcoma

Initial Regimens

  • All are integrase inhibitor with two nucleoside analogues
  • Consider one of the single-tablet regimens for HIV
    • Biktarvy 1 tablet PO once daily
    • Triumeq (if HLA B5701 negative): dolutegravir, abacavir, and lamivudine
    • Truvada (tenofovir/TDF and emtricitabine) with either dolutegravir or raltegravir
    • Stribild: elvitegravir/cobicistat/tenofovir disoproxil/emtricitabine
    • Complera: emtricitabine/rilpivirine/tenofovir disoproxil
  • Don't forget to add TMP-SMX DS 1 tablet PO daily if presumed low CD4 count

Further Reading